Stock Screener App

Frei -

Installieren

56.21

0.25% 0.14

after-market

Handel nachbörslich: 56.21

Protagonist Therapeutics Inc (PTGX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt PTGX? Forum Prognose

Finanzdaten der Protagonist Therapeutics Inc-Aktie (PTGX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	80.42% 5.546	28.32	4.675	4.167	254.95
Operating Expenses	0.09% 47.59	47.63	46.13	42.96	48.64
Benefits Costs and Expenses	0.42% 40.15	39.98	38.30	35.46	44.29
Costs And Expenses	0.42% 40.15	39.98	38.30	35.46	44.29
Operating Income/Loss	117.72% -42.04	-19.31	-41.45	-38.79	206.31
Income/Loss From Continuing Operations Before Tax	196.86% -34.60	-11.65	-33.63	-31.29	210.67
Income Tax Expense/Benefit	0.172	-	-0.42	-0.676	3.326
Income/Loss From Continuing Operations After Tax	198.34% -34.77	-11.65	-33.21	-30.62	207.34
Net Income/Loss	198.34% -34.77	-11.65	-33.21	-30.62	207.34
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.87% 63.51	62.96	61.77	61.31	60.86
Diluted Average Shares	0.87% 63.51	62.96	61.77	61.31	63.60
Basic Earnings Per Share	189.47% -0.55	-0.19	-0.54	-0.50	3.41
Diluted Earnings Per Share	189.47% -0.55	-0.19	-0.54	-0.50	3.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$35.92

1.18%

INCY

$84.92

2.30%

SMMT

$26.29

1.50%

INSM

$127.27

0.41%

BNTX

$112.55

0.85%

ONC

$319.32

0.63%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters